CVS Health's Insider Buying and Dividend Yields Attract Investors
ByAinvest
Tuesday, Jul 8, 2025 4:57 pm ET1min read
CVS--
The dividend represents a 3.99% yield, making it an attractive option for income-focused investors. CVS Health's dividend payout ratio of 63.48% indicates that its dividend is sufficiently covered by earnings [2]. Research analysts expect the company to earn $6.77 per share next year, with an expected future payout ratio of 39.3% [1].
Director Guy P. Sansone's recent purchase of 1,570 shares at $63.70 per share, totaling $100,090, signals insider confidence in the company's prospects. The transaction, disclosed in a legal filing with the Securities & Exchange Commission, represents a 15.04% increase in the director's position [1].
CVS Health's stock has a market cap of $84.18 billion, a P/E ratio of 15.89, and a price-to-earnings-growth ratio of 0.97. The company's stock has a 52-week low of $43.56 and a 52-week high of $72.51. Analysts have rated the stock with a consensus rating of "Moderate Buy" and a consensus price target of $75.06 [1].
The company's strong quarterly dividend history, favorable long-term growth rates, and insider buying make CVS Health an attractive value and profitability stock for investors. However, as with any investment, it is essential to conduct thorough research and consider your financial goals and risk tolerance before making any investment decisions.
References:
[1] https://www.marketbeat.com/instant-alerts/cvs-health-corporation-nysecvs-to-issue-quarterly-dividend-of-067-2025-07-07/
[2] https://www.marketscreener.com/quote/stock/CVS-HEALTH-CORPORATION-12230/news/Cvs-Health-Announces-A-Quarterly-Dividend-Payable-on-August-1-2025-50448582/
CVS Health Corporation has been named a top dividend stock with insider buying and a 3.99% yield. Director Guy P. Sansone recently invested $100,009 in 1,570 shares at $63.70 per share. The company has a strong quarterly dividend history and favorable long-term growth rates, making it an attractive value and profitability stock for investors.
CVS Health Corporation (NYSE: CVS), a leading pharmacy operator and healthcare services provider, has been recognized as a top dividend stock due to its strong quarterly dividend history and favorable long-term growth rates. The company recently announced a quarterly dividend of $0.665 per share, payable on August 1, 2025, to shareholders of record on July 22, 2025 [1].The dividend represents a 3.99% yield, making it an attractive option for income-focused investors. CVS Health's dividend payout ratio of 63.48% indicates that its dividend is sufficiently covered by earnings [2]. Research analysts expect the company to earn $6.77 per share next year, with an expected future payout ratio of 39.3% [1].
Director Guy P. Sansone's recent purchase of 1,570 shares at $63.70 per share, totaling $100,090, signals insider confidence in the company's prospects. The transaction, disclosed in a legal filing with the Securities & Exchange Commission, represents a 15.04% increase in the director's position [1].
CVS Health's stock has a market cap of $84.18 billion, a P/E ratio of 15.89, and a price-to-earnings-growth ratio of 0.97. The company's stock has a 52-week low of $43.56 and a 52-week high of $72.51. Analysts have rated the stock with a consensus rating of "Moderate Buy" and a consensus price target of $75.06 [1].
The company's strong quarterly dividend history, favorable long-term growth rates, and insider buying make CVS Health an attractive value and profitability stock for investors. However, as with any investment, it is essential to conduct thorough research and consider your financial goals and risk tolerance before making any investment decisions.
References:
[1] https://www.marketbeat.com/instant-alerts/cvs-health-corporation-nysecvs-to-issue-quarterly-dividend-of-067-2025-07-07/
[2] https://www.marketscreener.com/quote/stock/CVS-HEALTH-CORPORATION-12230/news/Cvs-Health-Announces-A-Quarterly-Dividend-Payable-on-August-1-2025-50448582/
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet